Related Experiment Video
Updated: Feb 8, 2026
07:52
Simultaneous EEG Monitoring During Transcranial Direct Current Stimulation
Published on: June 17, 2013
40.4K
Current and Ongoing Clinical Studies
Agessandro Abrahao1, Lorne Zinman1, Stephen Apple2
1Division of Neurology, Department of Medicine and Harquail Centre for Neuromodulation, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
Muscle & Nerve
|February 7, 2026
Summary
Ongoing studies evaluate edaravone (intravenous and oral suspension) for amyotrophic lateral sclerosis (ALS) treatment. Research aims to clarify efficacy, safety, and biological impact, supporting edaravone as a key ALS therapy option.
Area of Science:
- Neurology
- Pharmacology
- Clinical Research
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with limited treatment options.
- Edaravone, available as intravenous (IV) and oral suspension, is an emerging therapeutic agent for ALS.
- Understanding the full clinical utility of edaravone requires ongoing evaluation in diverse study settings.
Purpose of the Study:
- To provide a comprehensive overview of current and planned studies on edaravone for ALS treatment.
- To assess the efficacy, safety, and biological mechanisms of edaravone in various clinical contexts.
- To inform optimal treatment strategies and future therapeutic approaches for ALS.
Main Methods:
- Review of ongoing and completed clinical trials and observational studies.
- Analysis of data from postmarketing surveillance and natural history registries.
- Inclusion of biomarker data to explore edaravone's pathophysiologic impact.
Main Results:
- Multiple studies are evaluating both IV edaravone and oral edaravone suspension.
- Ongoing research includes long-term surveillance, natural history tracking, and biomarker analysis.
- Clinical trials have supported the safety, tolerability, and efficacy of edaravone formulations.
Conclusions:
- Current and ongoing studies collectively support edaravone as a valuable therapeutic option for ALS.
- Continued data collection from clinical trials and practice is crucial for refining edaravone treatment.
- These efforts will guide optimal strategies and combination therapies in the evolving ALS landscape.
Related Concept Videos
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
371
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
371
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
585
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
585
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
349
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
349
01:10Electrical Current
7.2K
Electrical current is defined as the rate at which charge flows. When there is a large current present, such as that used to run a refrigerator, a large amount of charge moves through the wire in a small amount of time. If the current is small, such as that used to operate a handheld calculator, a small amount of charge moves through the circuit over a long period of time. The SI unit for current is the ampere (A), named for the French physicist André-Marie Ampère (1775–1836).
7.2K
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
635
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
635
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
614
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
614